Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $2,928.84 billion, total revenue of $603.35 billion and a weighted average PE ratio of 34.00.

Market Cap
2,928.84B
Revenue
603.35B
Profits
86.13B
PE Ratio
34.00
Profit Margin
14.28%
Dividend Yield
2.06%

18 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company735.54B-2.02%1,625,80835.93B
2JNJJohnson & Johnson371.13B1.05%4,505,64881.80B
3MRKMerck & Co., Inc.332.34B-0.65%3,594,06761.40B
4ABBVAbbVie Inc.291.10B0.34%3,149,18654.40B
5AZNAstraZeneca PLC239.09B0.09%2,426,68747.61B
6NVSNovartis AG200.99B-0.51%689,27949.92B
7AMGNAmgen Inc.169.32B-0.65%1,724,30329.53B
8PFEPfizer Inc.164.39B0.35%27,367,70955.09B
9SNYSanofi112.79B-0.39%1,812,76851.60B
10GSKGSK plc91.60B-0.98%3,137,61939.41B
11BMYBristol-Myers Squibb Company89.63B-0.99%11,816,39545.53B
12GILDGilead Sciences, Inc.84.57B1.27%2,700,52727.45B
13BIIBBiogen Inc.33.61B-2.24%666,2039.66B
14GRFSGrifols, S.A.6.63B-0.26%785,4727.32B
15OGNOrganon & Co.5.55B-0.60%1,294,9306.35B
16AMRNAmarin Corporation plc376.23M-2.51%565,247277.46M
17SCLXScilex Holding Company157.65M6.32%547,19747.05M
18MIRAMIRA Pharmaceuticals, Inc.10.08M-4.34%88,164-